Arvaya Healthcare board approves draft letter of offer for rights issue up to Rs 210 crore
Board clears draft letter of offer for proposed partly paid-up equity rights issue aggregating up to Rs 210.00 cr; final terms and record date to follow.
Key takeaways
- Rights issue size up to Rs 210.00 cr, assuming full subscription and receipt of all call monies.
- Type of issuance is a Rights Issue of partly paid-up equity shares to eligible equity shareholders.
- Final issue price, rights entitlement ratio and record date will be decided later and intimated separately.
- Amount not exceeding Rs 210.00 cr is specified in the details table under Regulation 30.
- NSDL appointed as e-voting service provider and CS Chinmay Mohan Lele as Scrutinizer for the postal ballot.
Key terms
- Action
- Rights issue
- Terms
- Rs 210.00 cr
- Amount not exceeding Rs 210.00 cr for the rights issue
- Draft Letter of Offer approved for submission to BSE Limited
Arvaya Healthcare Limited has moved a step closer to its planned capital raise via a rights issue, with the board approving the draft letter of offer for submission to the stock exchange.
According to the board's outcome letter dated 4th November, 2026, the company will pursue a proposed rights issue of partly paid-up equity shares to existing shareholders, subject to finalisation of terms and regulatory approvals.
Key terms (as disclosed so far)
- Type of securities: Equity Shares (partly paid-up), as stated in Annexure A.
- Type of issuance: Rights Issue to eligible equity shareholders.
- Issue size: Amount aggregating up to Rs 210.00 cr (Rupees Two Hundred Ten Crore only), assuming full subscription, allotment and receipt of all call monies, as per the board's outcome letter.
- Total amount for which securities will be issued (approx.): "Amount not exceeding Rs 210.00 cr (Rupees Two Hundred Ten Crore Only)", as per the details table under Regulation 30.
- Record date: Not yet decided; to be intimated separately.
- Issue price: Not yet decided; to be determined by the Rights Issue Committee / the Board.
- Rights entitlement ratio: Not yet decided; to be announced later.
- Amount payable on application and on subsequent call(s): Not yet decided; to be communicated in due course.
The company has described this as a proposed Rights Issue of partly paid-up equity shares under Section 62(1)(a) of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The draft letter of offer ("DLOF") has been approved and adopted by the board for submission to BSE Limited, which is identified as the designated stock exchange for obtaining in-principle approval.
The filing makes clear that the final terms of the Rights Issue — including the issue price, rights entitlement ratio, amount payable on application and on subsequent call(s), and the record date — will be decided by the Rights Issue Committee / the Board, as applicable, and will be intimated to the stock exchange separately in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Eligibility and record date
Because the record date has not yet been fixed, the filing does not specify which shareholders will be eligible. Typically, shareholders whose names appear on the company's register as on the record date announced later by the company would be entitled to receive rights entitlements. Investors will need to watch for a separate stock exchange intimation where Arvaya Healthcare will disclose the record date and other final terms.
Other board decisions
In addition to the rights issue-related approvals, the board also approved the conduct of a postal ballot, including remote e-voting, under Sections 108 and 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, for seeking the approval of the members. As per the outcome letter:
- National Securities Depository Limited (NSDL) has been appointed as the e-voting service provider for the postal ballot.
- CS Chinmay Mohan Lele, Practising Company Secretary (Membership No. F-12351 / COP No. 28362), has been appointed as the Scrutinizer for the postal ballot and e-voting process.
The meeting of the Board of Directors commenced at 4.10 p.m. and concluded at 6:00 p.m., as recorded in the filing signed by Kaushal Uttam Shah, Managing Director (DIN: 02175130), dated 4th November 2026 at Pune.
The company has stated that a copy of this outcome is also being made available on its website at https://www.arvayahealth.com.
Track Arvaya Healthcare Ltd
Cruxal reads every Arvaya Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
